Results 211 to 217 of about 38,006 (217)

SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy

International Journal of Molecular Sciences, 2017
Daiji Kawanami, Kazunori Sango, Keiichiro Matoba   +2 more
exaly  

Risks Associated with SGLT2 Inhibitors: An Overview

Current Drug Safety, 2018
Anoop Kumar
exaly  

SGLT2 inhibitors: are they safe?

Postgraduate Medicine, 2018
Theodosios D. Filippatos, Moses Elisaf
exaly  

SGLT2 inhibitors-induced electrolyte abnormalities: An analysis of the associated mechanisms

Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 2018
Theodosios D. Filippatos, Moses Elisaf, G Liamis   +2 more
exaly  

The Cardioprotective and Anticancer Effects of SGLT2 Inhibitors

JACC: CardioOncology
Mohamed Dabour, Anne Blaes, Beshay N Zordoky   +2 more
exaly  

SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials

Diabetologia, 2017
Jiali Han, Yiqing Song, Huilin Tang
exaly  

SGLT2 inhibitors and AMPK: The road to cellular housekeeping?

Cell Biochemistry and Function
Hamid-Reza Nejabati, Yousef Faridvand, Shahab Masoumi   +2 more
exaly